Studies of Myocardial Protection in the Immature Heart. IV. Improved Tolerance of Immature Myocardium to Hypoxia and Ischemia by Intravenous Metabolic Support
Overview
Authors
Affiliations
Thirteen immature puppies (2 to 4 kg) underwent 1 hour of acute hypoxia (oxygen tension 25 to 30 mm Hg), followed by 45 minutes of normothermic global ischemia on total vented bypass with normal blood reperfusion. Ventricular function was assessed by inscribing Starling function curves and measuring stroke work indices before hypoxia and after reperfusion. Seven puppies (control) received normal saline infusion at 4 ml/kg/hr. Six other puppies received a 4 ml/kg/hr intravenous infusion of glutamate/aspartate, glucose-insulin-potassium, mercaptopropionyl glycine, carnitine, and catalase during hypoxia and reperfusion. In control hearts, acute hypoxia depleted myocardial glutamate and aspartate by 52% (p less than 0.05 versus prehypoxia) and 48% (p less than 0.05 versus prehypoxia) and caused severe hemodynamic deterioration (55% decrease of stroke work index) (p less than 0.05 versus prehypoxia); three of seven (43%) required premature institution of bypass. Postischemic left ventricular function recovered to only 40% of control levels (p less than 0.05 versus prehypoxia). In contrast, intravenous metabolic infusions maintained tissue glutamate (p less than 0.05 versus control group) and aspartate (p less than 0.05 versus control group) in treated hearts during hypoxia and allowed cardiac index to rise 20% (p less than 0.05 versus prehypoxia); all treated hearts tolerated 1 hour of hypoxia, and stroke work recovered 70% (p less than 0.05 versus control group) of stroke work index after subsequent ischemia. Impaired tolerance of immature hearts to acute hypoxia and subsequent ischemia is due to substrate depletion. This impairment can be reduced by intravenous metabolic support during hypoxia and reperfusion and leads to improved recovery of postischemic function.
Angeli E, Martens S, Careddu L, Petridis F, Quarti A, Ciuca C Interact Cardiovasc Thorac Surg. 2021; 32(2):319-324.
PMID: 33398332 PMC: 8906757. DOI: 10.1093/icvts/ivaa262.
Oxidative Stress after Surgery on the Immature Heart.
Fudulu D, Angelini G Oxid Med Cell Longev. 2016; 2016:1971452.
PMID: 27123154 PMC: 4830738. DOI: 10.1155/2016/1971452.
Effect of esmolol on myocardial protection in pediatrics congenital heart defects.
Fazelifar S, Bigdelian H Adv Biomed Res. 2015; 4:246.
PMID: 26693471 PMC: 4685641. DOI: 10.4103/2277-9175.170241.
Normoxic and hyperoxic cardiopulmonary bypass in congenital heart disease.
Mokhtari A, Lewis M Biomed Res Int. 2014; 2014:678268.
PMID: 25328889 PMC: 4189843. DOI: 10.1155/2014/678268.
Ghorbel M, Mokhtari A, Sheikh M, Angelini G, Caputo M Physiol Genomics. 2012; 44(22):1098-106.
PMID: 22991208 PMC: 3524652. DOI: 10.1152/physiolgenomics.00072.2012.